(1 - 16 von 18
)
NZZ: UBS-Manager in London von Vorwürfen entlastet | NZZ
Der UBS-Manager John Pottage ist vom Vorwurf entlastet worden, Mängel der Risikokontrolle in seiner Londoner Abteilung nicht rasch genug ...
UBS banker wins appeal against UK watchdog | Reuters
www.reuters.com
— In a rare successful appeal against a fine imposed by the regulator, John Pottage was cleared of misconduct by Britain's Upper Tribunal over ... › article
FSA loses supervision test case
www.investmentweek.co.uk
The FSA was seeking to fine John Pottage, the former chief executive of UBS's UK wealth management division, £100,000 for misconduct after uncovering a ... › ...
Ex-UBS wealth chief 'confused' over regulator's attempt to fine him -...
www.investmentnews.com
Investment news and analysis for financial advisers. Extensive coverage and expert comment on important topics in the financial advisory industry.
Fined UBS Wealth chief missed warning signs, says FSA
www.professionaladviser.com
John Pottage did not heed warning signs that risk controls in his division were ineffective after he became CEO, lawyers for the FSA said yesterday. › ...
FCA fines for AML failings: important guidance for CEOs and boards
www.shlegal.com
... failings) was explored in the leading case of John Pottage v The Financial Services Authority (in which this firm acted for John Pottage).
GSK, J&J say monthly injection keeps HIV controlled - PMLiVE
www.pmlive.com
John Pottage. The long-acting antiretroviral therapy (ART) could mean that more patients adhere to the treatment regimen needed to suppress ...
Live Q&A on COVID Colgate University
alumni.colgate.edu
Join us for a live Q&A event with John Pottage '74, Christina Farrell '90, and David Beier '70. Hear from three health care experts in this special ...
ViiV Healthcare begins phase III programme with...
viivhealthcare.com
ViiV Healthcare begins phase III programme with dolutegravir/rilpivirine combination for HIV maintenance therapy
ViiV Healthcare presents data from dolutegravir study
www.labmate-online.com
John Pottage, chief scientific and medical officer, ViiV Healthcare, said: "People living with HIV who have developed resistance to more than one ... › ...
FSA "did not establish misconduct" from alleged CEO compliance...
www.pinsentmasons.com
— The Upper Tribunal (Tax and Chancery Chamber) overturned a £100,000 fine imposed on John Pottage, the former head of UBS' UK wealth ... › f...
ViiV submits two-drug regimen for HIV in Europe - Life4me+
life4me.plus
... that are based on our belief that no one should take more medicines than they need,” added John Pottage, ViiV's chief scientific and medical officer. › news › viiv-s...
ViiV veteran science chief to step down - BioPharma Dive
www.biopharmadive.com
— John Pottage, the chief science and medical officer at the majority GlaxoSmithKline-owned ViiV Healthcare, will soon step down, ... › ...
sortiert nach Relevanz / Datum